PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,520,000 | +90.7% | 39,179 | 0.0% | 0.02% | +58.3% |
Q4 2018 | $797,000 | -68.4% | 39,179 | -28.8% | 0.01% | -62.5% |
Q3 2018 | $2,524,000 | -33.9% | 55,048 | -14.8% | 0.03% | -39.6% |
Q2 2018 | $3,820,000 | +135.1% | 64,585 | +170.4% | 0.05% | +112.0% |
Q1 2018 | $1,625,000 | -24.8% | 23,882 | +9.3% | 0.02% | -19.4% |
Q4 2017 | $2,160,000 | -24.2% | 21,856 | -8.1% | 0.03% | -22.5% |
Q3 2017 | $2,849,000 | -18.2% | 23,792 | -40.3% | 0.04% | -24.5% |
Q2 2017 | $3,481,000 | +180.5% | 39,834 | +19.4% | 0.05% | +152.4% |
Q1 2017 | $1,241,000 | +34.7% | 33,369 | +11.2% | 0.02% | +16.7% |
Q4 2016 | $921,000 | -54.2% | 30,000 | 0.0% | 0.02% | -48.6% |
Q3 2016 | $2,012,000 | – | 30,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |